The TriGUARD 3™ Cerebral Embolic Protection Device is designed to cover and protect all three major cerebral aortic arch vessels during Transcatheter Aortic Valve Replacement (TAVR) procedures.
TAMPA, Fla., July 29, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care,
July 29, 2020Read MoreTAMPA, Fla., June 16, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care,
June 16, 2020Read MoreMerger Establishes US and EMEA Presence for the Preeminent Chinese Structural Heart Company HANGZHOU, China and CAESAREA, Israel and TAMPA, Florida
January 09, 2019Read MoreKeystone Heart TriGUARD Data Review Jeffrey Moses Conclusions: Overt and Covert stroke are significant complications of TAVR which may be o
December 03, 2018Read MoreTamim Nazif Conclusions: TriGUARD 3™ offers complete 3 vessel cerebral embolic protection for TAVR Specific design improvements optimize
December 03, 2018Read More